SOM230 (Pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 10, 2010, Pages 760-763

  Bode, H ^a   Seiz, M ^a   Lammert, A ^a   Brockmann, M A ^a   Back, W ^a   Hammes, H P ^a   Thome C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

cancer; Cushing; hormones; pituitary adenoma

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; INSULIN; OCTREOTIDE; PASIREOTIDE; TEMOZOLOMIDE;

ADRENALECTOMY; ADULT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CONTINUOUS INFUSION; CORTICOTROPIN RELEASE; FEMALE; GLUCOCORTICOSTEROID DEFICIENCY; HEALTH STATUS; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS ADENOMA; LIVER METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOSURGERY; SALVAGE THERAPY; THROMBOCYTOPENIA;

ADRENOCORTICOTROPIC HORMONE; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; DACARBAZINE; FEMALE; HUMANS; MIDDLE AGED; PITUITARY NEOPLASMS; SALVAGE THERAPY; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 78349239330     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1253419     Document Type: Article

References (17)

1. Ragel BT, Couldwell WT. Pituitary carcinoma: a review of the literature. Neurosurg Focus 2004 16 Article7
2. Sidibé EH. Pituitary carcinoma. Anatomic and clinical features of cases reported in literature. Neurochirurgie 2007 53 284-288
3. Kaltsas GA, Nomikos P, Kontogeorgos G, et al. CLINICAL REVIEW: Diagnosis and Management of Pituitary Carcinomas. J Clin Endocrinol Metab 2005 90 3089-3099
4. Gaffey TA, Scheithauer BW, Lloyd RV, et al. Corticotroph carcinoma of the pituitary: a clinicopathological study. J Neurosurg 2002 96 352-360
5. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary Carcinoma A Clinicopathologic Study of 15 Cases. Cancer 1997 79 804-812
6. Landman RE, Horwith M, Peterson RE, et al. Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature. J Clin Endocrinol Metab 2002 87 3084-3089
7. Stupp R, Mason WP, van den Bent MJ, et al European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005 352 978-996
8. Fadul CE, Kominsky AL, Meyer LP, et al. Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 2006 105 621-626
9. Lim S, Shahinian H, Maya MM, et al. Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 2006 7 518-520
10. Hagen C, Schroeder HD, Hansen S, et al. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Eur J Endocrinol 2009 161 631-637
11. Moyes VJ, Alusi G, Sabin HI, et al. Treatment of Nelson's syndrome with temozolomide. Eur J Endocrinol 2009 160 115-119
12. Mohammed S, Kovacs K, Mason W, et al. xUse of temozolomide in aggressive pituitary tumors: case report. Mohammed S, Kovacs K, Mason W, Smyth H, Cusimano MD. Neurosurgery 2009 64 E773E774
13. Guzel A, Tatli M, Senturk S, et al. Pituitary Carcinoma Presenting with Multiple Metastases: Case Report. J Child Neurol 2008 23 1467-1471
14. Boscaro M, Ludlam WH, Atkinson B, et al. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab 2009 94 115-122
15. Batista DL, Zhang X, Gejman R, et al. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab 2006 91 4482-4488
16. Schmid HA. Pasireotide (SOM230): Development, mechanism of action and potential applications. Mol Cell Endocrinol 2008 286 69-74
17. Hofland LJ, van der Hoek J, Feelders R, et al. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. 2005 152 645-654